QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 800 mg sevelamer hydrochloride
Renalamer (sevelamer hydrochloride) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
PVC / Al blister packs of 180 tablets in packing boxes are available commercially.
The recommended starting dose of Renalamer is 2.4 g or 4.8 g per day based on clinical needs and serum phosphorus level. Renalamer must be taken three times per day with meals.
MARKETING AUTHORIZATION HOLDER